Movement Alert｜BeOne Medicines Falls 3.85% in Regular Trading, Major Shareholder Reduction Coupled with Prolonged Biotech Sector Weakness

Market Focus06-02

On June 2, BeOne Medicines fell 3.85% in regular trading, trading at 165.7 HKD/share, with trading volume of 222 million HKD.

On the news front, Baker Bros. Advisors LP, an affiliated fund of board directors Julian Baker and Felix Baker, recently sold approximately $190 million worth of shares. While the fund retains board seats and holds approximately 8.21% of shares outstanding, the substantial reduction has weighed on market sentiment. Additionally, the Hong Kong-listed innovative drug sector has been in correction mode for over eight months since last September, with the sector benchmark index declining more than 30% during this period.

Within the Biotechnology sector, the broader sell-off continued today. AKESO fell 3.54%, 3SBIO dropped 7.02%, Innovent Biologics declined 3.89%, SKB Bio lost 6.57%, and Remegen fell 4.91%. As a heavyweight leader in the sector, BeOne Medicines remains under sustained downward pressure from both company-specific and sector-wide headwinds.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1148955361?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-02 09:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1148955361","market":"us","top_or_hot":-1,"title":"Movement Alert｜BeOne Medicines Falls 3.85% in Regular Trading, Major Shareholder Reduction Coupled with Prolonged Biotech Sector Weakness","media":"Market Focus","content":"<p><p>On June 2, BeOne Medicines fell 3.85% in regular trading, trading at 165.7 HKD/share, with trading volume of 222 million HKD.</p><p>On the news front, Baker Bros. Advisors LP, an affiliated fund of board directors Julian Baker and Felix Baker, recently sold approximately $190 million worth of shares. While the fund retains board seats and holds approximately 8.21% of shares outstanding, the substantial reduction has weighed on market sentiment. Additionally, the Hong Kong-listed innovative drug sector has been in correction mode for over eight months since last September, with the sector benchmark index declining more than 30% during this period.</p><p>Within the Biotechnology sector, the broader sell-off continued today. AKESO fell 3.54%, 3SBIO dropped 7.02%, Innovent Biologics declined 3.89%, SKB Bio lost 6.57%, and Remegen fell 4.91%. As a heavyweight leader in the sector, BeOne Medicines remains under sustained downward pressure from both company-specific and sector-wide headwinds.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜BeOne Medicines Falls 3.85% in Regular Trading, Major Shareholder Reduction Coupled with Prolonged Biotech Sector Weakness</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜BeOne Medicines Falls 3.85% in Regular Trading, Major Shareholder Reduction Coupled with Prolonged Biotech Sector Weakness\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-02 09:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 2, BeOne Medicines fell 3.85% in regular trading, trading at 165.7 HKD/share, with trading volume of 222 million HKD.</p><p>On the news front, Baker Bros. Advisors LP, an affiliated fund of board directors Julian Baker and Felix Baker, recently sold approximately $190 million worth of shares. While the fund retains board seats and holds approximately 8.21% of shares outstanding, the substantial reduction has weighed on market sentiment. Additionally, the Hong Kong-listed innovative drug sector has been in correction mode for over eight months since last September, with the sector benchmark index declining more than 30% during this period.</p><p>Within the Biotechnology sector, the broader sell-off continued today. AKESO fell 3.54%, 3SBIO dropped 7.02%, Innovent Biologics declined 3.89%, SKB Bio lost 6.57%, and Remegen fell 4.91%. As a heavyweight leader in the sector, BeOne Medicines remains under sustained downward pressure from both company-specific and sector-wide headwinds.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06160","symbol_name":"百济神州","start_time":0,"source_url":"","article_id":"1148955361","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1148955361","pubTimestamp":1780365198,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 2, BeOne Medicines fell 3.85% in regular trading, trading at 165.7 HKD/share, with trading volume of 222 million HKD.On the news front, Baker Bros. Advisors LP, an affiliated fund of board...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06160":"百济神州"},"translate_title":"动向提示|BeOne Medicines常规交易下跌3.85%，大股东减持叠加生物科技板块长期疲软","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06160":1},"content_text":"On June 2, BeOne Medicines fell 3.85% in regular trading, trading at 165.7 HKD/share, with trading volume of 222 million HKD.On the news front, Baker Bros. Advisors LP, an affiliated fund of board directors Julian Baker and Felix Baker, recently sold approximately $190 million worth of shares. While the fund retains board seats and holds approximately 8.21% of shares outstanding, the substantial reduction has weighed on market sentiment. Additionally, the Hong Kong-listed innovative drug sector has been in correction mode for over eight months since last September, with the sector benchmark index declining more than 30% during this period.Within the Biotechnology sector, the broader sell-off continued today. AKESO fell 3.54%, 3SBIO dropped 7.02%, Innovent Biologics declined 3.89%, SKB Bio lost 6.57%, and Remegen fell 4.91%. As a heavyweight leader in the sector, BeOne Medicines remains under sustained downward pressure from both company-specific and sector-wide headwinds.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1148955361","isCrawlerRequest":true}